Related by context. Frequent words. (Click for all words.) 77 Drug Candidate 74 Inhibits 74 Monoclonal Antibody 73 Preclinical Data 73 Inhibitor 72 Clinical Trial Results 72 Initiates Phase 72 Induces 72 Low Dose 72 Presents Positive 72 Antagonist 70 Combination Therapy 70 Completes Enrollment 70 Monotherapy 70 receptor agonists 69 Phase III Clinical Trial 69 Small Molecule 69 receptor antagonist 69 Chronic Hepatitis C 68 Pivotal Phase 68 Inhibitors 68 Tolerability 68 Phase III Trial 68 Dasatinib 68 Elderly Patients 68 Agonist 68 Shows Promise 67 Pulmonary Arterial Hypertension 67 Pivotal Phase III 67 Study Demonstrates 67 Metastatic Melanoma 67 FDA Clears 67 Patients Treated 66 partial agonist 66 Lenalidomide 66 Significantly Reduces 66 receptor antagonists 66 Epratuzumab 66 Bortezomib 66 Patient Enrollment 66 Pivotal Trial 66 Voreloxin 66 receptor agonist 66 FDA Accepts 66 Cancer Cells 66 Extended Release 66 Vascular Endothelial Growth 65 Benign Prostatic Hyperplasia 65 Overactive Bladder 65 Insulin Resistance 65 induces apoptosis 65 Ofatumumab 65 selective inhibitor 65 Intranasal 65 Receptor 65 FDA Approves 65 peroxisome proliferator activated 65 Drug Resistant 65 RNAi Therapeutics 65 Chronic Lymphocytic Leukemia 65 Inhibit 64 Bevacizumab 64 Generic Version 64 Inhibition 64 Bavituximab 64 N methyl 64 liposomal formulation 64 Prostate Cancer Patients 64 Adenosine 64 Metastatic Colorectal Cancer 64 Antagonists 64 Kinase 64 Meta Analysis 63 hypoxia inducible factor 63 orally bioavailable 63 Antisense 63 Irinotecan 63 humanized anti 63 Receives FDA Clearance 63 Oral Presentation 63 Advanced Prostate Cancer 63 Monoclonal Antibodies 63 Postmenopausal Women 63 Panzem R 63 tyrosine kinase inhibitor 63 Targeted Therapy 63 potent inhibitor 63 Heart Failure Patients 62 Anti TNF 62 Hepatitis C Virus 62 Reduces Risk 62 kinase inhibitor 62 Erlotinib 62 Receptors 62 Autoimmune Diseases 62 Diabetic Patients 62 EGFr 62 Increases Risk 62 Immunogenicity 62 Linaclotide 62 Cholesterol Drug